News & Updates
Filter by Specialty:
Vaccines protect liver disease patients against severe COVID-19
Patients with liver disease develop antibodies and T-cell responses following three shots of COVID-19 vaccines, while those who have been infected with SARS-CoV-2 develop mild symptoms only, reports a recent study.
Vaccines protect liver disease patients against severe COVID-19
20 Jan 2024
PAGED-B score predicts HCC risk in patients entering into CHB
A novel risk score, PAGED-B, may be used to predict hepatocellular carcinoma (HCC) development at the time of transition into hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB), suggests a study.
PAGED-B score predicts HCC risk in patients entering into CHB
20 Jan 2024
HCC incidence rare in autoimmune hepatitis, tied to obesity, cirrhosis
The incidence of hepatocellular carcinoma (HCC) remains low in patients with autoimmune hepatitis (AIH) even after developing cirrhosis, according to a study. Factors such as obesity, cirrhosis, and AIH/primary sclerosing cholangitis (PSC) variant syndrome can increase the risk of HCC incidence.
HCC incidence rare in autoimmune hepatitis, tied to obesity, cirrhosis
19 Jan 2024
Parental smoking, asthma, respiratory tract infections in childhood linked to adult OSA
Parental smoking, maternal asthma, and frequent lower respiratory tract infections before the age of 7 years are predictive of obstructive sleep apnoea (OSA) development during adulthood, suggests a study.
